Ashling Henderson

Experience

• 

  Queen's University Belfast

  May 2014 - Aug 2014

  Masters Research student

  Research project: engineering interferon-alpha producing stromal cells for the conditional deletion of leukaemia oncogenes.

• 

  Randox

  Oct 2014 - May 2015

  Research Scientist

  Involved in developing, optimising and troubleshooting ELISA bases assays for the detection of Oncology biomarkers.

• 

  Almac Group

  Jun 2015 - Aug 2018

  Associate Scientist

  Involved in several high-throughput driven research projects dedicated to the discovery and development of novel drugs for the treatment of cancer.

• 

  Belfast Health and Social Care Trust

  Sept 2018 - Aug 2020

  Trainee Clinical Scientist

  Laboratory and clinical experience in the following departments: Biochemistry, Genetics, Immunology, Haematology and Blood Transfusion. Involved in patient sample identification, preparation, analysis, result interpretation, troubleshooting and communication of results.

• 

  UCL

  Feb 2021 - Apr 2023

  Supporting the daily operations of 2 high profile Prostate Cancer clinical trials with a combined 1400 patients, 4 academic partners and 17 commercial partners. Clinical Trials: - ReIMAGINE Risk: aims to improve risk stratification, appropriate treatment allocation and more cost effective care for men undergoing investigation for prostate cancer.- RECONCILE: Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors

  • Clinical Trial Practitioner

    Aug 2021 - Apr 2023

  • Tissue Technician

    Feb 2021 - Aug 2021
• 

  The Royal Marsden NHS Foundation Trust

  May 2023 - now

  Lung Research Responsible for the running of an international breast cancer phase II CTIMP recruiting patients across 40 sites in collaboration with multiple vendors including Pfizer and AstraZeneca.

  • Senior Clinical Trial Manager

    Jun 2024 - now

  • Clinical Trial Manager

    May 2023 - Jun 2024